Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Respiratory quotient in patients with non-insulin-dependent diabetes mellitus treated with insulin and oral hypoglycemic agents.

Nakaya Y, Ohnaka M, Sakamoto S, Niwa Y, Okada K, Nomura M, Hara T, Kusonoki M.

Ann Nutr Metab. 1998;42(6):333-40.

PMID:
9895421
2.

Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin.

Avignon A, Lapinski H, Rabasa-Lhoret R, Caubel C, Boniface H, Monnier L.

Diabetes Obes Metab. 2000 Aug;2(4):229-35.

PMID:
11225656
3.

Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.

Biesenbach G, Bodlaj G, Ebner S, Biesenbach P, Pieringer H.

Int Urol Nephrol. 2011 Dec;43(4):1155-60. doi: 10.1007/s11255-010-9804-x. Epub 2010 Jul 20.

PMID:
20640938
4.

Nateglinide with glibenclamide examination using the respiratory quotient (RQ).

Harada S, Nomura M, Nakaya Y, Ito S.

J Med Invest. 2006 Aug;53(3-4):303-9.

5.

No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate.

Wolever TM, Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH.

Diabetes Care. 1998 Oct;21(10):1612-8.

PMID:
9773719
6.

Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ.

Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C, Ravussin E.

Am J Physiol. 1990 Nov;259(5 Pt 1):E650-7.

PMID:
2240203
7.

The use of Acarbose in Type 2 diabetic patients in secondary failure: effects on glycaemic control and diet induced thermogenesis.

Brooks B, Molyneaux L, Zilkens R, Ross G, Yue DK.

Diabetes Res Clin Pract. 1998 Dec;42(3):175-80.

PMID:
9925348
10.
11.

[Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen].

Bu S, Guo XH, Yang WY, Lu GZ, Yang ZJ, Ren TT, Gao Y.

Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3115-8. Chinese.

PMID:
18269868
13.
15.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
16.

Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.

Savage S, Estacio RO, Jeffers B, Schrier RW.

Proc Assoc Am Physicians. 1997 Mar;109(2):181-9.

PMID:
9069587
18.

Decreased ratio of fat to carbohydrate oxidation with increasing age in Pima Indians.

Rising R, Tataranni PA, Snitker S, Ravussin E.

J Am Coll Nutr. 1996 Jun;15(3):309-12.

PMID:
8935448
19.

Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.

Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.

Diabetes Care. 1994 May;17(5):397-404.

PMID:
8062606
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk